OvaScience (OVAS) Announces Global Healthcare Strategist Marc Kozin Joins Company’s Board Of Directors
1/13/2014 7:35:46 AM
OvaScienceSM, (NASDAQ: OVAS), a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, announced today the appointment of Marc Kozin, former President of L.E.K. Consulting’s North American practice, to the Company’s Board of Directors.
“Marc has been advising healthcare companies on the growth of their businesses, technology platforms, and product lines for close to 30 years,” said Michelle Dipp, M.D., Ph.D., Chief Executive Officer of OvaScience.
Help employers find you! Check out all the jobs and post your resume.
comments powered by